Kailera Therapeutics, Inc. (KLRA)
NASDAQ: KLRA · Real-Time Price · USD
23.72
+0.21 (0.89%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Kailera Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Market Capitalization | 2,962 | - | - |
| Enterprise Value | 2,297 | - | - |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.00 |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.02 |
| Net Debt / EBITDA Ratio | 4.06 | 4.06 | 7.15 |
| Net Debt / FCF Ratio | 5.25 | 5.25 | 0.94 |
| Quick Ratio | 11.83 | 11.83 | 25.35 |
| Current Ratio | 12.02 | 12.02 | 25.70 |
| Return on Equity (ROE) | -36.90% | -36.90% | - |
| Return on Assets (ROA) | -22.73% | -22.73% | - |
| Return on Capital Employed (ROCE) | -24.50% | -24.50% | -14.30% |
Source: S&P Capital IQ. Standard template.
Financial Sources.